A Model of Basement Membrane-Associated Gene Signature Predicts Liver Hepatocellular Carcinoma Response to Immune Checkpoint Inhibitors

A Model of Basement Membrane-Associated Gene Signature Predicts Liver Hepatocellular Carcinoma Response to Immune Checkpoint Inhibitors

Liver hepatocellular carcinoma (LIHC) is a highly lethal malignant tumor originating from the digestive system, which is a serious threat to human health. In recent years, immunotherapy has shown significant therapeutic effects in the treatment of LIHC, but only for a minority of patients. The basem...

Full description

Bibliographic Details
Main Authors:	Jiajia Shen, Zhihong Wei, Lizhi Lv, Jingxiong He, Suming Du, Fang Wang, Ye Wang, Lin Ni, Xiaojin Zhang, Fan Pan
Format:	Article
Language:	English
Published:	Hindawi Limited 2023-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2023/7992140

Similar Items

Identification of Basement Membrane-Related Signatures in Gastric Cancer
by: Jinyun Wang, et al.
Published: (2023-05-01)

Comprehensive analysis of basement membrane and immune checkpoint related lncRNA and its prognostic value in hepatocellular carcinoma via machine learning
by: Ze Jin, et al.
Published: (2023-10-01)

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
by: Ying Xu, et al.
Published: (2021-01-01)

Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma
by: Jiajia Du, et al.
Published: (2024-01-01)

Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
by: Qimeng Gao, et al.
Published: (2021-12-01)

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
by: Nitin N. Katariya, et al.
Published: (2022-04-01)

Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma
by: Ruili Ding, et al.
Published: (2023-04-01)

Prognostic roles of a novel basement membranes-related gene signature in lung adenocarcinoma
by: Xingzhuang Zhu, et al.
Published: (2023-02-01)

Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
by: Zeynep Akbulut, et al.
Published: (2024-04-01)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
by: Diederick J. van Doorn, et al.
Published: (2020-12-01)

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
by: Mohamed A. Abd El Aziz, et al.
Published: (2020-10-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
by: Ji Won Han, et al.
Published: (2021-09-01)

Studies on renal basement membranes
by: Cotter, T, et al.
Published: (1979)

The basement membrane zone of the nail.
by: Sinclair, R, et al.
Published: (1994)

Studies on basement membrane permeation
by: Tein, M
Published: (1994)

Research Progress on Immune Checkpoint Inhibitors in Treatment of Hepatocellular Carcinoma
by: CAO Jiali, et al.
Published: (2023-05-01)

Identification of a basement membrane-related genes signature with immune correlation in bladder urothelial carcinoma and verification in vitro
by: Yanze Li, et al.
Published: (2023-10-01)

Integration of basement membrane-related genes in a risk signature for prognosis in clear cell renal cell carcinoma
by: Bowen Xia, et al.
Published: (2024-02-01)

Basement-Membrane-Related Gene Signature Predicts Prognosis in WHO Grade II/III Gliomas
by: Zhaogang Zhang, et al.
Published: (2022-10-01)

A Prognostic Model for Predicting Liver Cancer Patients Based On Immune Checkpoint Gene-Related Basement Membrane Genes, And Analyzing Immunity and Potential Drug Candidates
by: Yiyang Chen, et al.
Published: (2022-11-01)

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Anne Dyhl-Polk, et al.
Published: (2021-06-01)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Vito Longo, et al.
Published: (2019-10-01)

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
by: Yue Chen, et al.
Published: (2022-06-01)

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
by: Qingqing Xie, et al.
Published: (2022-09-01)

Basement membranes : cell and molecular biology /
by: Kefalides, Nicholas A., et al.
Published: (2005)

Isolation and Purification of Basement Membrane Collagen
by: Roghayeh Pourkabir
Published: (1997-03-01)

Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors
by: Shen J, et al.
Published: (2024-01-01)

Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report
by: Periklis Kyriazis, et al.
Published: (2021-04-01)

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
by: Hsu HM, et al.
Published: (2023-10-01)

Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor
by: Chunhui Jiang, et al.
Published: (2023-06-01)

Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
by: Ran Qin, et al.
Published: (2023-12-01)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
by: Nikolaos Machairas, et al.
Published: (2022-04-01)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
by: Francesco Tovoli, et al.
Published: (2020-10-01)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
by: Samantha M. Ruff, et al.
Published: (2023-06-01)

Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy
by: Jin Zhang, et al.
Published: (2023-03-01)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
by: Nicola Personeni, et al.
Published: (2021-11-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
by: Zhanjun Guo, et al.
Published: (2022-03-01)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
by: Raphael Mohr, et al.
Published: (2021-03-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
by: Huang JT, et al.
Published: (2022-11-01)